{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:13Z","timestamp":1793377873310,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020655","name":"European Health and Digital Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health at Charite","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.034","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:07:30Z","timestamp":1784560050000},"page":"5872-5889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations"],"prefix":"10.1016","volume":"34","author":[{"given":"Viktor","family":"Glaser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily Jo","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Fuster-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Jackson","family":"Aird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Huth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Nitulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Kassing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Marie","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Luca","family":"Flugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberts","family":"K\u0101rkli\u0146\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1532-7510","authenticated-orcid":false,"given":"Shona","family":"Shaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Pouzolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Andrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Ellery","family":"Corn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-7978","authenticated-orcid":false,"given":"Jonas","family":"Kath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-3579","authenticated-orcid":false,"given":"Dimitrios Laurin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.034_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004446","article-title":"Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression","volume":"10","author":"Mueller","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.034_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib3","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.2023020973","article-title":"Integration of \u03b6-deficient CARs into the CD3\u03b6 gene conveys potent cytotoxicity in T and NK cells","volume":"143","author":"Kath","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.034_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.omtm.2022.03.018","article-title":"Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells","volume":"25","author":"Kath","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.034_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.034_bib7","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1182\/blood-2012-01-405365","article-title":"A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR","volume":"119","author":"Torikai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.034_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.865424","article-title":"Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing","volume":"13","author":"Wagner","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","article-title":"Targeted Disruption of the \u03b2 2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cell Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.034_bib10","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/nar\/gkv182","article-title":"Genome-wide CIITA-binding profile identifies sequence preferences that dictate function versus recruitment","volume":"43","author":"Scharer","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.07.034_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64945-3","article-title":"HLA matching or CRISPR editing of HLA class I\/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model","volume":"16","author":"McCallion","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib12","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1172\/JCI83092","article-title":"Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition","volume":"126","author":"Cherkassky","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.07.034_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133977","article-title":"TGF-\u03b2 inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors","volume":"5","author":"Tang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.07.034_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymthe.2020.09.011","article-title":"CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients","volume":"29","author":"Amini","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.034_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","article-title":"Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy","volume":"576","author":"Wei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54794-x","article-title":"Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK\/STAT signaling pathway","volume":"15","author":"Adachi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s43018-024-00892-0","article-title":"ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion","volume":"6","author":"Cheng","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.034_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41467-022-35583-w","article-title":"Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy","volume":"14","author":"Trefny","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn5647","article-title":"Enhanced T cell effector activity by targeting the Mediator kinase module","volume":"378","author":"Freitas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.07.034_bib20","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","article-title":"Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function","volume":"175","author":"Shifrut","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.034_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-05126-w","article-title":"RASA2 ablation in T cells boosts antigen sensitivity and long-term function","volume":"609","author":"Carnevale","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004832117","article-title":"Frequent loss of heterozygosity in CRISPR-Cas9\u2013edited early human embryos","volume":"118","author":"Alanis-Lobato","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.034_bib23","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41588-024-01758-y","article-title":"High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR\u2013Cas9 editing","volume":"56","author":"Lazar","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.07.034_bib24","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","article-title":"Frequent aneuploidy in primary human T cells after CRISPR\u2013Cas9 cleavage","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","author":"Mitelman","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.034_bib26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A T to G C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib28","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1038\/s41467-019-13007-6","article-title":"Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors","volume":"10","author":"Webber","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib29","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41467-021-22009-2","article-title":"CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells","volume":"12","author":"Kluesner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.07.034_bib31","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s41587-024-02488-6","article-title":"Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations","volume":"43","author":"Cullot","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib32","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1038\/s41467-023-40344-4","article-title":"Simultaneous inhibition of DNA-PK and Pol\u03f4 improves integration efficiency and precision of genome editing","volume":"14","author":"Wimberger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib75","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.07.034_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2023.1130736","article-title":"T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds","volume":"5","author":"Rhiel","year":"2023","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymthe.2026.07.034_bib33","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.034_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm9106","article-title":"Precise CRISPR-Cas-mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells","volume":"8","author":"Tran","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.07.034_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.07.034_bib37","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ymthe.2025.01.045","article-title":"Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer","volume":"33","author":"Du","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.034_bib38","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-023-01888-4","article-title":"High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition","volume":"42","author":"Selvaraj","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13059-023-02928-7","article-title":"Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells","volume":"24","author":"Glaser","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A Method to Quantify Base Editing from Sanger Sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.07.034_bib41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2026.07.033","article-title":"A singular base-editing platform for polyfunctional multiplex engineering of immune cells","author":"Skeate","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.034_bib42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.sbi.2004.07.007","article-title":"Folding of helical membrane proteins: the role of polar, GxxxG-like and proline motifs","volume":"14","author":"Senes","year":"2004","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.07.034_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Sig Transduct Target. Ther."},{"key":"10.1016\/j.ymthe.2026.07.034_bib77","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41587-022-01418-8","article-title":"High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails","volume":"41","author":"Shy","year":"2023","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.ymthe.2026.07.034_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102568","article-title":"Single-stranded HDR templates with truncated Cas12a-binding sequences improve knock-in efficiencies in primary human T cells","volume":"36","author":"Nitulescu","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.034_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-019-1161-z","article-title":"Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors","volume":"569","author":"Gr\u00fcnewald","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-024-07456-3","article-title":"Selective haematological cancer eradication with preserved haematopoiesis","volume":"630","author":"Garaud\u00e9","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib47","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1182\/bloodadvances.2022009397","article-title":"CAR NK-92 cell\u2013mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products","volume":"7","author":"Kath","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.07.034_bib49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.2022015825","article-title":"Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL","volume":"140","author":"Diorio","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.034_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2427216122","article-title":"Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR\/Cas9 nuclease-engineered T cells","volume":"122","author":"Engel","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.034_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/0008-5472.CAN-21-1692","article-title":"CRISPR\/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.034_bib53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.034_bib54","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1038\/s41375-021-01282-6","article-title":"Base-edited CAR T cells for combinational therapy against T cell malignancies","volume":"35","author":"Georgiadis","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2026.07.034_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009560","article-title":"Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.034_bib56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa2309728","article-title":"CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma","volume":"392","author":"Harrison","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.034_bib57","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood.2024024166","article-title":"Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System","volume":"143","author":"Elsallab","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.034_bib58","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1038\/s41467-022-30896-2","article-title":"Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing","volume":"13","author":"Jo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib59","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41587-024-02531-6","article-title":"SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci","volume":"43","author":"Chang","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41587-023-01779-8","article-title":"A highly efficient transgene knock-in technology in clinically relevant cell types","volume":"42","author":"Allen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib61","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.ymthe.2024.06.033","article-title":"An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation","volume":"32","author":"Porreca","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.034_bib62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41551-023-01032-2","article-title":"Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes","volume":"7","author":"Foss","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.07.034_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.034_bib64","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-021-01133-w","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib65","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41587-022-01527-4","article-title":"Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases","volume":"41","author":"Yarnall","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt5199","article-title":"Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase","volume":"388","author":"Witte","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.07.034_bib67","article-title":"Versatile and efficient non-viral integration of large transgenes in human T cells via CRISPR knock-in and engineered integrases","author":"Kassing","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.07.034_bib68","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41467-020-15887-5","article-title":"Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.034_bib69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41587-024-02235-x","article-title":"Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens","volume":"43","author":"Walsh","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.034_bib70","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41586-023-06835-6","article-title":"Base-editing mutagenesis maps alleles to tune human T cell functions","volume":"625","author":"Schmidt","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.034_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: A web-based tool for identifying and validating CRISPR\/Cas off-target sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.034_bib72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.07.034_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR Edits from Sanger Trace Data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:33:24Z","timestamp":1793374404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006027"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.034","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}